Kam Leong

Kam Leong

Columbia University in the City of New York

H-index: 136

North America-United States

Professor Information

University

Columbia University in the City of New York

Position

Biomedical Engineering

Citations(all)

69446

Citations(since 2020)

23665

Cited By

55567

hIndex(all)

136

hIndex(since 2020)

77

i10Index(all)

513

i10Index(since 2020)

351

Email

University Profile Page

Columbia University in the City of New York

Research & Interests List

biomaterials

drug and gene delivery

tissue engineering

photonics

Top articles of Kam Leong

Isotropic multi-scale neuronal reconstruction from high-ratio expansion microscopy with contrastive unsupervised deep generative models

Background and objectiveCurrent methods for imaging reconstruction from high-ratio expansion microscopy (ExM) data are limited by anisotropic optical resolution and the requirement for extensive manual annotation, creating a significant bottleneck in the analysis of complex neuronal structures.MethodsWe devised an innovative approach called the IsoGAN model, which utilizes a contrastive unsupervised generative adversarial network to sidestep these constraints. This model leverages multi-scale and isotropic neuron/protein/blood vessel morphology data to generate high-fidelity 3D representations of these structures, eliminating the need for rigorous manual annotation and supervision. The IsoGAN model introduces simplified structures with idealized morphologies as shape priors to ensure high consistency in the generated neuronal profiles across all points in space and scalability for arbitrarily large …

Authors

Gary Han Chang,Meng-Yun Wu,Ling-Hui Yen,Da-Yu Huang,Ya-Hui Lin,Yi-Ru Luo,Ya-Ding Liu,Bin Xu,Kam W Leong,Wen-Sung Lai,Ann-Shyn Chiang,Kuo-Chuan Wang,Chin-Hsien Lin,Shih-Luen Wang,Li-An Chu

Journal

Computer Methods and Programs in Biomedicine

Published Date

2024/2/1

Bacterial therapies at the interface of synthetic biology and nanomedicine

Bacteria are emerging as living drugs to treat a broad range of disease indications. However, the inherent advantages of these replicating and immunostimulatory therapies also carry the potential for toxicity. Advances in synthetic biology and the integration of nanomedicine can address this challenge through the engineering of controllable systems that regulate spatial and temporal activation for improved safety and efficacy. Here, we review recent progress in nanobiotechnology-driven engineering of bacteria-based therapies, highlighting limitations and opportunities that will facilitate clinical translation.

Authors

Jaeseung Hahn,Suwan Ding,Jongwon Im,Tetsuhiro Harimoto,Kam W Leong,Tal Danino

Published Date

2024/2

Multi-Omics Profiling of Human Hippocampus Reveals Increased Inflammation and Transcription Instability in Major Depressive Disorder

BackgroundTo decipher hippocampus cellular and molecular changes in major depression (MDD), we sequenced single-nucleus RNA (snRNA-seq) and accessible chromatin (snATAC-seq), spatial RNA (Visium, 10X Genomics) and multiome via deterministic barcoding in intact tissue (DBiT-seq).MethodsLibraries of 293,236 nuclei from 16 males (age 43±13, RIN> 7) were sequenced, data preprocessed and integrated. We used the RNA velocity (scVelo) to compute RNA synthesis, splicing, and degradation, ran Cell2location algorithm to deconvolute the cellular composition in spatial spots. Differentially expressed genes (DEG) were identified by the “FindMarkers” function in Seurat.ResultsWe identified all canonical neurons, oligodendrocytes, microglia, vasculature, epithelial, choroid plexus, Cajal-Retzius, and oligodendrocyte progenitor cells. We discovered a neural progenitor cell cluster (NPC) enriched for …

Authors

Yang Xiao,Madeline Mariani,Graham Su,Yanxiang Deng,Cheick A Sissoko,Tianyu Li,Sai Ma,Zhiliang Bai,Yang Liu,Gorazd Rosoklija,Tingting Wu,Andrew J Dwork,Rene Hen,J John Mann,Rong Fan,Kam Leong,Maura Boldrini

Journal

Biological Psychiatry

Published Date

2024/5/15

Human vascular organoids with a mosaic AKT1 mutation recapitulate Proteus syndrome

Vascular malformation, a key clinical phenotype of Proteus syndrome, lacks effective models for pathophysiological study and drug development due to limited patient sample access. To bridge this gap, we built a human vascular organoid model replicating Proteus syndrome's vasculature. Using CRISPR/Cas9 genome editing and gene overexpression, we created induced pluripotent stem cells (iPSCs) embodying the Proteus syndrome-specific AKTE17K point mutation for organoid generation. Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections. This could be due to the significant vasculogenesis induced by AKT overactivation. This phenomenon likely stems from boosted vasculogenesis triggered by AKT overactivation, leading to increased vascular sprouting. Additionally, a notable increase in dysfunctional PDGFRbeta+ mural cells, impaired in matrix secretion, was observed in these AKT-overactivated organoids. The application of AKT inhibitors (ARQ092, AZD5363, or GDC0068) reversed the vascular malformations; the inhibitors' effectiveness was directly linked to reduced connectivity in the organoids. In summary, our study introduces an innovative in vitro model combining organoid technology and gene editing to explore vascular pathophysiology in Proteus syndrome. This model not only simulates Proteus syndrome vasculature but also holds potential for mimicking vasculatures of other genetically driven diseases. It represents an advance in drug development for rare diseases, historically plagued by slow progress.

Authors

Siyu He,Yuefei Zhu,Shradha Chauhan,Daniel Naveed Tavakol,Jong Ha Lee,Rayna Batya-Leia Berris,Cong Xu,Jounghyun Lee,Caleb Lee,Sarah Cai,Shannon McElroy,Gordana Vunjak-Novakovic,Raju Tomer,Elham Azizi,Bin Xu,Yeh-Hsing Lao,Kam W Leong

Journal

bioRxiv

Published Date

2024

Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery

Lipid nanoparticles (LNPs) have recently emerged as successful gene delivery platforms for a diverse array of disease treatments. Efforts to optimize their design for common administration methods such as intravenous injection, intramuscular injection, or inhalation, revolve primarily around the addition of targeting ligands or the choice of ionizable lipid. Here, we employed a multi-step screening method to optimize the type of helper lipid and component ratios in a plasmid DNA (pDNA) LNP library to efficiently deliver pDNA through intraduodenal delivery as an indicative route for oral administration. By addressing different physiological barriers in a stepwise manner, we down-selected effective LNP candidates from a library of over 1000 formulations. Beyond reporter protein expression, we assessed the efficiency in non-viral gene editing in mouse liver mediated by LNPs to knockdown PCSK9 and ANGPTL3 …

Authors

Yining Zhu,Shuting Sarah Cai,Jingyao Ma,Leonardo Cheng,Christine Wei,Ataes Aggarwal,Wu Han Toh,Charles Shin,Ruochen Shen,Jiayuan Kong,Shuming Alan Mao,Yeh-Hsing Lao,Kam W Leong,Hai-Quan Mao

Journal

Biomaterials

Published Date

2024/4/4

Enabling continuous immune cell recirculation on a microfluidic array to study immunotherapeutic interactions in a recapitulated tumour microenvironment

The effects of immunotherapeutics on interactions between immune and cancer cells are modulated by multiple components in the tumour microenvironment (TME), including endothelium and tumour stroma, which provide both a physical barrier and immunosuppressive stimuli. Herein, we report a recirculating chip to enable continuous immune cell recirculation through a microfluidic cell array to include these crucial players. This system consists of a three-layered cell array (μFCA) spatially emulating the TME, with tailored fluidic circuits establishing T cell recirculation. This platform enables the study of dynamics among the TME, immune cells in a circulatory system and cancer cell responses thereof. Through this system, we found that tumour endothelium hindered T cell infiltration into the reconstructed breast cancer tumour compartment. This negative effect was alleviated when treated with anti-human PD-L1 …

Authors

Chun-Wei Chi,Yeh-Hsing Lao,AH Rezwanuddin Ahmed,Siyu He,Taha Merghoub,Kam W Leong,Sihong Wang

Journal

Lab on a Chip

Published Date

2024

Tackling Severe Neutrophilic Inflammation in Airway Disorders with Functionalized Nanosheets

Severe airway inflammatory disorders impose a significant societal burden, and the available treatments are unsatisfactory. High levels of neutrophil extracellular trap (NET) and cell-free DNA (cfDNA) were detected in the inflammatory microenvironment of these diseases, which are closely associated with persistent uncontrolled neutrophilic inflammation. Although DNase has proven to be effective in mitigating neutrophilic airway inflammation in mice by reducing cfDNA and NET levels, its clinical use is hindered by severe side effects. Here, we synthesized polyglycerol-amine (PGA) with a series of hydroxyl/amine ratios and covered them with black phosphorus (BP) nanosheets. The BP nanosheets functionalized with polyglycerol-50% amine (BP-PGA50) efficiently lowered cfDNA levels, suppressed toll-like receptor 9 (TLR9) activation and inhibited NET formation in vitro. Importantly, BP-PGA50 nanosheets …

Authors

Zhaoxu Tu,Yuefei Zhu,Wenlong Gao,Ming Liu,Yi Wei,Changyi Xu,Yongqiang Xiao,Yihui Wen,Jian Li,Kam W Leong,Weiping Wen

Journal

ACS nano

Published Date

2024/2/20

Compositions and methods for treating depression and anxiety

The present disclosure provides, inter alia, compositions and methods for treating or ameliorating the effect of a disorder such as, eg, anxiety or depression in a subject, with less or no off-and/or on-target side effects. Also provided are methods for treating such disorder in a pregnant woman.

Published Date

2024/3/21

academic-engine

Useful Links